Patent ID: 11857564
Assignee: OMRIX BIOPHARMACEUTICALS LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A hemostatic composition comprising:
an anion exchanger; wherein the anion exchanger comprises one or more positively-charged groups bound to a matrix; wherein said positively-charged groups comprise diethylaminoethyl (DEAE) groups, diethyl-(2-hydroxypropyl)aminoethyl groups, or combinations thereof;
a calcium salt; and
optionally, a pharmaceutically acceptable carrier;, wherein:
(i) a polyanionic polymer is not present in the hemostatic composition;
(ii) thrombin is not present in the hemostatic composition;
(iii) the calcium is present at a concentration of from 1 to 100 mM or the ratio between the anion exchanger and the calcium salt in the composition ranges from 1:5 to 1:70, respectively, by weight
(iv) the hemostatic composition comprises a homogenous blend of said matrix and calcium, and wherein:
(v) the hemostatic composition is a blend in the form selected from powder, slurry and liquid.